Novel fibrinogen mutation (γ 313 Ser→Asn) associated with hypofibrinogenemia in two unrelated families

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 1, 2006, Pages 63-67

  Meyer, Michael ^a   Bergmann, Frauke ^b   Brennan, Stephen O ^c  

^a UNIVERSITY OF APPLIED SCIENCES JENA   (Germany)

^b MVZ Wagnerstibbe   (Germany)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

D domain; Fibrinogen variants; Hypofibrinogenemia

Indexed keywords

AMINO ACID; ASPARAGINE; DNA; DODECYL SULFATE SODIUM; FIBRINOGEN; POLYPEPTIDE; SERINE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DNA SCREENING; ELECTROPHORESIS; ELECTROSPRAY MASS SPECTROMETRY; FAMILY; FEMALE; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HYPOFIBRINOGENEMIA; MALE; MUTATIONAL ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADOLESCENT; ADULT; AFIBRINOGENEMIA; AMINO ACID SUBSTITUTION; DNA MUTATIONAL ANALYSIS; FEMALE; FIBRINOGENS, ABNORMAL; HUMANS; MALE; POINT MUTATION; PROTEIN CONFORMATION;

EID: 31644435079     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1007/0-387-28831-7_4     Document Type: Article

References (23)

1. Henschen A, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Zwaal RFA, Hemker HC, editors. Blood coagulation. Amsterdam: Elsevier Science Publishers; 1986, pp. 171-241.
2. Doolittle RF. Fibrinogen and fibrin. In: Bloom F, Thomas DP, editors. Haemostasis and thrombosis, 2nd ed. Edinburgh: Churchill Livingstone; 1981163-191.
3. Brennan SO, Fellowes AP, George PM. Molecular mechanisms of hypo-and afibrinogenemia. Ann NY Acad Sci 2001; 936:91-100.
4. Lefebvre P, Velasco PT, Dear A, Lounes KC, Lord ST, Brennan SO, et al. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AαIVS4+1G>T mutation and an AαGln328 truncation (fibrinogen Keokuk). Blood 2004; 103:2571-2576.
5. Mimuro J, Hamano A, Tanaka T, Madoiwa KS, Sugo T, Matsuda M, Sakata Y. Hypofibrinogenemia caused by a nonsense mutation in the fibrinogen Bβ chain gene. J Thromb Haemost 2003; 1:2356-2359.
6. Asselta R, Duga S, Spena S, Peyvandi F, Castaman G, Malcovati M, et al. Missense or splicing mutation ? The case of a fibrinogen Bβ-chain mutation causing severe hypofibrinogenemia. Blood 2004; 103:3051-3054.
7. Brennan SO, Wyatt JM, May S, De Caigney S. Hypofibrinogenemia due to a novel 316 Asp→Tyr substitution in the fibrinogen Bβ chain. Thromb Haemost 2001; 85:450-453.
8. Maghzal GJ, Brennan SO, Fellowes AP, Spearing R, George PM. Familial hypofibrinogenemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg→His (fibrinogen Merivale). Biochim Biophys Acta 2003; 1645:146-151.
9. Brennan SO, Fellowes AP, Faed JM, George PM. Hypofibrinogenemia in an individual with 2 coding (γ82 A→G and Bβ235 P→L) and 2 noncoding mutations. Blood 2000; 95:1709-1713.
10. Terasawa F, Okumura N, Kitano K, Hayashida N, Shimosaka M, Okazaki M, Lord ST. Hypofibrinogenemia associated with a heterozygous missense mutation γ153Cys to Arg (Matsumoto IV): in vitro expression demonstrates defective secretion of the variant fibrinogen. Blood 1999; 94:4122-4131.
11. Dear A, Dempfle CE, Brennan SO, Kirschstein W, Gearge PM. Fibrinogen Mannheim II: a novel γ307 His→Tyr substitution in the γD domain causes hypofibrinogenemia. J Thromb Haemost 2004; 2:2194-2199.
12. SNP database. http://www.ncbi.nlm.nih.gov/projects/SNP/
13. SNP database. http://pga.gs.washington.edu/finished_genes.html
14. Kazal LA, Amsel S, Miller OP, Tocantins LM. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exptl Biol Med 1963; 113:989-994.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
16. Brennan SO. Electrospray ionisation analysis of human fibrinogen. Thromb Haemost 1997; 78:1055-1058.
17. Chung DW, Harris JE, Davie EW. Nucleotide sequences of the three genes coding for human fibrinogen. In: Liu CY, Chien S, editors. Fibrinogen, thrombosis, coagulation, and fibrinolysis. New York: Plenum Press; 1986, pp. 39-48.
18. Doolittle RF. A detailed consideration of a principal domain of vertebrate fibrinogen and its relatives. Protein Sci 1992; 1:1563-1577.
19. Koopman J, Haverkate F, Briet E, Lord ST. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the γ chain gene causing defective calcium binding and impaired fibrin polymerization. J Biol Chem 1991; 266:13456-13461.
20. Hogan KA, Gorkun OV, Lounes KC, Coates AI, Weisel JW, Hantgan RR, Lord ST. Recombinant fibrinogen Vlissingen/Frankfurt IV. The deletion of residues 319 and 320 from the γ chain of fibrinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation. J Biol Chem 2000; 275:17778-17785.
21. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 1997; 389:455-462.
22. Brennan SO, Wyatt GM, Medicina D, Callea F, George PM. Fibrinogen Brescia: hepatic endoplasmic reticulum storage and hypofibrinogemia because of a γ284 Gly→Arg mutation. Am J Pathol 2000; 157:189-196.
23. Brennan SO, Maghzal G, Shneider BL, Gordon R, Magid MS, George PM. Novel fibrinogen γ375 Arg→Trp mutation (fibrinogen Aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology 2002; 36:652-658.